Equipalazone Original Sachets 1g**
DECHRA UK (PHARMACEUTICALS)
Equipalazone Original Sachets 1g** from DECHRA UK (PHARMACEUTICALS) is supplied as a oral powder.
LEGAL CLASSIFICATION:POM-V
THIS MEDICINE REQUIRES A PRESCRIPTION.
This can be uploaded on this page or it can be sent to mail@vets4u.uk.
We also require information about you and your Pet for us to be able to dispense your Pets medicine, please provide us with all your up to date information in the Question boxes below.
A link to the Medicine SPC on the VMD Product database can be found here: VMD Product Database
Post-Authorisation Assessment Report: PAAR (PDF)
Active Ingredient(s)
Phenylbutazone
Pack & Presentation
Form: Oral powder · Pack size: PK 100
Suitable Species
Horses
Indications
For the treatment of musculoskeletal disorders in horses and ponies where the antiinflammatory and analgesic properties of phenylbutazone can offer relief. Examples of conditions normally considered suitable for treatment with phenylbutazone include lameness associated with osteoarthritic conditions, acute and chronic laminitis, bursitis and carpitis, and in the reduction of post-surgical soft tissue reaction.
Storage & Shelf Life
Do not store above 25°C. Store in a dry place. Immediate packaging Sachets of a paper/polyethylene outer layer and aluminium/polyethylene inner layer in a cardboard box.
Owner Handling & Safety
The veterinary medicinal product should be handled with care at all times to reduce the risk of accidental ingestion, skin contact or dust inhalation. If accidental skin or eye contact occurs, the site should be washed immediately with water. If the product is ingested, seek medical advice and show the product packaging.
Contraindications & Warnings
Do not administer with other non-steroidal anti-inflammatory drugs (NSAIDs) concurrently or within 24 hours of each other. Do not use in animals suffering from cardiac, hepatic or renal disease; where there is the possibility of gastrointestinal ulceration or bleeding; or where there is evidence of a blood dyscrasia. Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Use in Pregnancy & Lactation
The safety of the veterinary medicinal product in pregnancy has not been established. Pregnancy: Use during pregnancy should be avoided whenever possible, particularly during the first trimester.
Regulatory Information
- Legal category: POM-V
- Marketing authorisation holder: Dechra Limited, Snaygill Industrial Estate, Keighley Road, Skipton, North Yorkshire, BD23 2RW, United Kingdom.
- MA number: GB: VM 50406/5043 NI: VM 50406/3038
Important Notice
The information on this page is provided for general guidance only and does not replace the advice of a qualified veterinary surgeon. Always follow the directions provided on the product packaging and by your veterinary practice. If your animal's condition does not improve, worsens, or any side effects occur, contact your veterinary surgeon immediately.
